11:47 AM
 | 
Apr 24, 2019
 |  BC Extra  |  Financial News

Hong Kong firms to invest in Singapore biotechs with $200M fund

Aptorum Group and Aeneas Capital said Wednesday they are launching a $200 million healthcare and life science fund that could be used to invest in Singapore biotech start-ups. The companies said they...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >